Follow
Antreas Afantitis (EL: Ανδρέας Αφαντίτης)
Antreas Afantitis (EL: Ανδρέας Αφαντίτης)
Managing Director NovaMechanics Ltd, Coordinator: NanoSolveIT & CompSafeNano H2020 Projects
Verified email at novamechanics.com - Homepage
Title
Cited by
Cited by
Year
Synthesis and evaluation of the antioxidant and anti-inflammatory activity of novel coumarin-3-aminoamides and their alpha-lipoic acid adducts
G Melagraki, A Afantitis, O Igglessi-Markopoulou, A Detsi, M Koufaki, ...
European journal of medicinal chemistry 44 (7), 3020-3026, 2009
3182009
Collaborative development of predictive toxicology applications
B Hardy, N Douglas, C Helma, M Rautenberg, N Jeliazkova, V Jeliazkov, ...
Journal of cheminformatics 2 (1), 1-29, 2010
1232010
A novel QSAR model for predicting induction of apoptosis by 4-aryl-4H-chromenes
A Afantitis, G Melagraki, H Sarimveis, PA Koutentis, J Markopoulos, ...
Bioorganic & medicinal chemistry 14 (19), 6686-6694, 2006
1142006
Design and Synthesis of Novel Quinolinone-3-aminoamides and Their a-Lipoic Acid Adducts as Antioxidant and Antiiflammatory Agents
A Detsi, D Bouloumbasi, KC Prousis, M Koufaki, G Athanasellis, ...
Journal of Medicinal Chemistry 50 (10), 2450, 2007
1112007
Prediction of high weight polymers glass transition temperature using RBF neural networks
A Afantitis, G Melagraki, K Makridima, A Alexandridis, H Sarimveis, ...
Journal of molecular structure: THEOCHEM 716 (1-3), 193-198, 2005
1052005
Ligand-based virtual screening procedure for the prediction and the identification of novel β-amyloid aggregation inhibitors using Kohonen maps and Counterpropagation …
A Afantitis, G Melagraki, PA Koutentis, H Sarimveis, G Kollias
European Journal of Medicinal Chemistry 46 (2), 497-508, 2011
1042011
QSAR study on para-substituted aromatic sulfonamides as carbonic anhydrase II inhibitors using topological information indices
G Melagraki, A Afantitis, H Sarimveis, O Igglessi-Markopoulou, ...
Bioorganic & Medicinal Chemistry 14 (4), 1108-1114, 2006
1022006
Identification of putative estrogen receptor-mediated endocrine disrupting chemicals using QSAR-and structure-based virtual screening approaches
L Zhang, A Sedykh, A Tripathi, H Zhu, A Afantitis, VD Mouchlis, ...
Toxicology and applied pharmacology 272 (1), 67-76, 2013
912013
Enalos KNIME nodes: Exploring corrosion inhibition of steel in acidic medium
G Melagraki, A Afantitis
Chemometrics and Intelligent Laboratory Systems 123, 9-14, 2013
832013
Prediction of intrinsic viscosity in polymer–solvent combinations using a QSPR model
A Afantitis, G Melagraki, H Sarimveis, PA Koutentis, J Markopoulos, ...
Polymer 47 (9), 3240-3248, 2006
812006
Enalos InSilicoNano platform: an online decision support tool for the design and virtual screening of nanoparticles
G Melagraki, A Afantitis
RSC advances 4 (92), 50713-50725, 2014
712014
Predictive QSAR workflow for the in silico identification and screening of novel HDAC inhibitors
G Melagraki, A Afantitis, H Sarimveis, PA Koutentis, G Kollias, ...
Molecular diversity 13 (3), 301-311, 2009
662009
A novel simple QSAR model for the prediction of anti-HIV activity using multiple linear regression analysis
A Afantitis, G Melagraki, H Sarimveis, PA Koutentis, J Markopoulos, ...
Molecular Diversity 10 (3), 405-414, 2006
632006
A novel QSAR model for predicting the inhibition of CXCR3 receptor by 4-N-aryl-[1, 4] diazepane ureas
A Afantitis, G Melagraki, H Sarimveis, O Igglessi-Markopoulou, G Kollias
European Journal of Medicinal Chemistry 44 (2), 877-884, 2009
612009
NanoSolveIT Project: Driving nanoinformatics research to develop innovative and integrated tools for in silico nanosafety assessment
A Afantitis, G Melagraki, P Isigonis, A Tsoumanis, DD Varsou, ...
Computational and structural biotechnology journal 18, 583-602, 2020
582020
In Silico Exploration for Identifying Structure–Activity Relationship of MEK Inhibition and Oral Bioavailability for Isothiazole Derivatives
G Melagraki, A Afantitis, H Sarimveis, O Igglessi‐Markopoulou, ...
Chemical biology & drug design 76 (5), 397-406, 2010
572010
A combined LS-SVM & MLR QSAR workflow for predicting the inhibition of CXCR3 receptor by quinazolinone analogs
A Afantitis, G Melagraki, H Sarimveis, PA Koutentis, ...
Molecular diversity 14 (2), 225-235, 2010
572010
Prediction of toxicity using a novel RBF neural network training methodology
G Melagraki, A Afantitis, K Makridima, H Sarimveis, ...
Journal of molecular modeling 12 (3), 297-305, 2006
552006
Molecular modeling on pyrimidine-urea inhibitors of TNF-α production: an integrated approach using a combination of molecular docking, classification techniques, and 3D-QSAR CoMSIA
VD Mouchlis, G Melagraki, T Mavromoustakos, G Kollias, A Afantitis
Journal of chemical information and modeling 52 (3), 711-723, 2012
542012
Advances in de novo drug design: From conventional to machine learning methods
VD Mouchlis, A Afantitis, A Serra, M Fratello, AG Papadiamantis, V Aidinis, ...
International journal of molecular sciences 22 (4), 1676, 2021
512021
The system can't perform the operation now. Try again later.
Articles 1–20